17-Hydroxyprogesterone Neonatal/Infant

ALUKARD vs Ro: eligibility rigor versus rapid telehealth flow

Ro and ALUKARD both serve telehealth demand, but their operating assumptions differ. Ro leans into broad, efficient pathway delivery; ALUKARD leans into...

Bone density and DEXA: who should test and when

Bone loss is usually silent until fracture. DEXA is one of the few tools that identifies risk early enough to act. This guide explains who should test, how...

Creatine for women: what the evidence supports

Creatine is still underused in women despite strong data on strength, recovery, and healthy aging support. Misconceptions about bloating and hormonal...